Adagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
January 16, 2024 17:01 ET
|
Adagene Inc.
- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansion showed clinical benefit including confirmed responses at higher, more frequent and...
Compass Therapeutics Provides Corporate Update
January 05, 2024 08:00 ET
|
Compass Therapeutics
We continue to open clinical sites and enroll patients in COMPANION-002, the Phase 2/3 randomized study of CTX-009 (DLL4 x VEGF-A bispecific antibody) in patients with advanced biliary tract cancer...
Groundbreaking Early-Age Onset Colorectal Cancer Think Tank Aims to Transform Colorectal Cancer Outcomes
November 29, 2023 13:49 ET
|
Fight Colorectal Cancer
Springfield, Mo., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Fight Colorectal Cancer (Fight CRC), a national advocacy organization, is leading a groundbreaking initiative to combat the alarming rise of...
Monoclonal Antibodies Market Size Worth USD 572.62 Billion in 2032 | Emergen Research
November 28, 2023 08:17 ET
|
Emergen Research
Vancouver, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The global monoclonal antibodies market size was USD 204.42 billion in 2022 and is expected to register a revenue CAGR of 10.8% during the forecast...
Dubai Government Grants Insurance Reimbursement for Biomerica’s EZ Detect™ Colorectal Disease Screening Test
September 26, 2023 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that the Dubai government has officially approved insurance reimbursement for the EZ...
Fight Colorectal Cancer Hosts Congressional Black Caucus Panel to Tackle Disparities and Drive Progress
September 21, 2023 13:53 ET
|
Fight Colorectal Cancer
Springfield, Mo., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Colorectal cancer, the second-leading cause of cancer-related deaths in the United States, disproportionately impacts the Black community....
Climb for a Cure Raises $1 Million to Support High-Impact Colorectal Cancer Research
September 06, 2023 13:28 ET
|
Fight Colorectal Cancer
Springfield, Mo., Sept. 06, 2023 (GLOBE NEWSWIRE) -- In an inspiring display of unity, determination, and community support, Fight Colorectal Cancer’s Climb for a Cure event has achieved a...
Fecal Calprotectin Test Market revenue to hit USD 350 Million by 2035, says Research Nester
August 23, 2023 07:30 ET
|
Research Nester
New York, Aug. 23, 2023 (GLOBE NEWSWIRE) -- The global fecal calprotectin test market size is predicted to grow at a CAGR of over ~12% from 2023 to 2035. The market is projected to garner a revenue...
CVS Health to Begin Nationwide In-Store Sales of Biomerica’s EZ Detect™ Colorectal Disease Screening Test
August 03, 2023 08:19 ET
|
Biomerica, Inc.
Over 7,000 CVS Pharmacy Stores to sell the EZ Detect™ TestSimple 2 minute at-home test detects an early warning sign of colorectal cancer IRVINE, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) --...
Global Radiation Oncology Market Expected to Reach $21.14 Billion by 2030: Technological Advancements and Global Cancer Burden Drive Growth
July 25, 2023 07:08 ET
|
Research and Markets
Dublin, July 25, 2023 (GLOBE NEWSWIRE) -- The "Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By...